Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1246

2.

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service.

Transfusion. 2002 Oct;42(10):1365-72.

PMID:
12423522
3.

Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.

Weusten JJ, van Drimmelen HA, Lelie PN.

Transfusion. 2002 May;42(5):537-48.

PMID:
12084161
4.

The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia.

Yao F, Seed C, Farrugia A, Morgan D, Cordner S, Wood D, Zheng MH.

Am J Transplant. 2007 Dec;7(12):2723-6.

6.

Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.

Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.

Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.

PMID:
19309474
7.

Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.

Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.

Transfusion. 2005 Oct;45(10):1670-5.

PMID:
16181219
8.

Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.

CMAJ. 2003 Oct 14;169(8):767-73.

9.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
10.

Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.

Shang G, Seed CR, Wang F, Nie D, Farrugia A.

Transfusion. 2007 Mar;47(3):529-39.

PMID:
17319836
11.

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.

Transfusion. 2007 Feb;47(2):316-25.

PMID:
17302779
12.

The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.

Whyte GS, Savoia HF.

Med J Aust. 1997 Jun 2;166(11):584-6.

PMID:
9201178
13.

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ.

N Engl J Med. 1996 Jun 27;334(26):1685-90.

14.

Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru.

Laguna-Torres VA, Pérez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A, Flores W, Retamal A, Mendoza S, Cruz M, Monge Z, Lavalle M, Gutiérrez J, Málaga J, Soto E, Loayza N, Bolívar D, Reyna R, Mendoza C, Oré M, González J, Suárez M, Montano SM, Sánchez JL, Sateren W, Bautista CT, Olson JG, Xueref S.

J Clin Virol. 2005 Dec;34 Suppl 2:S61-8.

PMID:
16461242
15.
16.

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.

Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ; German Red Cross NAT Study Group.

Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.

PMID:
18466173
17.

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.

Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR; SIMTI Research Group.

Transfusion. 2008 Oct;48(10):2205-13. doi: 10.1111/j.1537-2995.2008.01813.x. Epub 2008 Jul 8.

PMID:
18631163
18.

The risk of transfusion-transmitted infections in sub-Saharan Africa.

Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I.

Transfusion. 2010 Feb;50(2):433-42. doi: 10.1111/j.1537-2995.2009.002402.x. Epub 2009 Oct 15. Review.

PMID:
19843290
19.

Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.

Schleicher S, Schieffer M, Jürgens S, Wehner HD, Flehmig B.

Ig Sanita Pubbl. 2005 Sep-Oct;61(5):435-50.

PMID:
17214028

Supplemental Content

Support Center